BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2017
View Archived Issues
Novartis reports key developments of first quarter 2017
Read More
New phase III trial explores use of simvastatin in children with Noonan syndrome
Read More
Xenon acquires potassium channel modulator for the treatment of epilepsy
Read More
Sage Therapeutics begins phase I development of SAGE-718
Read More
FDA grants breakthrough therapy designation to lorlatinib for ALK-positive metastatic NSCLC
Read More
Aldeyra initiates phase III study of ADX-102 for noninfectious anterior uveitis
Read More
ProQR Therapeutics cleared to begin phase I/II study of QR-110 in LCA 10
Read More
RCM-1 reduces lung inflammation in response to HDM and recombinant IL-13 in vivo
Read More
Promising interim phase I results for autologous EBV-specific T-cell therapy for MS
Read More
Amgen profiles pipeline progress of first quarter 2017
Read More
FOCUS results show promise of dimethyl fumarate in pediatric relapsing-remitting MS
Read More
Preclinical efficacy of novel HBV expression inhibitor RG-7834 in combination therapy
Read More
FDA approves Brineura to treat CLN2 disease
Read More
New mouse model of acute alcoholic hepatitis developed
Read More
Cellectar reports preclinical data on CLR-131 and CLR-125
Read More
FDA approves Stivarga for second-line treatment of hepatocellular carcinoma
Read More
Wnt signaling inhibitors patented by Suzhou Yunxuan Yiyao Keji Youxian Gongsi
Read More
Inventiva discovers novel YAP/TEAD interaction inhibitors
Read More
Pfizer seeks Japanese approval for inotuzumab ozogamicin in ALL
Read More
Polyphor synthesizes new Pin1 inhibitors
Read More
Universite Pierre et Marie Curie and collaborators identify novel RIP-1 inhibitors
Read More
BridgeBio launches Eidos Therapeutics to develop AG-10 for TTR amyloidosis
Read More
Sichuan Haisco describes novel muscarinic M3 antagonists and/or beta2-adrenergic receptor agonists
Read More
Shanghai Hengrui and Jiangsu Hengrui Medicine discover mu-opioid receptor agonists
Read More
Tavalisse accepted as proprietary name for fostamatinib disodium in U.S.
Read More
Myriad Genetics and Clovis Oncology enter companion diagnostic collaboration for Rubraca
Read More
Antibe Therapeutics begins IND-enabling preclinical studies for analgesic ATB-352
Read More
New TLR5 polymorphism found to be associated with HCC in chronic hepatitis B patients
Read More
Savara closes merger with Mast Therapeutics
Read More
Agios and Aurigene in license agreement on small-molecule inhibitors of cancer metabolism target
Read More
